Understanding the sodium pump and its relevance to disease.
Na,K-ATPase (sodium pump; EC 3.6.1.37) is present in the membrane of most eukaryotic cells and controls directly or indirectly many essential cellular functions. Regulation of this enzyme (ion transporter) and its individual isoforms is believed to play a key role in the etiology of some pathological processes. The sodium pump is the only known receptor for the cardiac glycosides. However, endogenous ligands structurally similar to digoxin or ouabain may control the activity of this important molecular complex. Here we review the structure and function of Na,K-ATPase, its expression and distribution in tissues, and its interaction with known ligands such as the cardiac glycosides and other suspected endogenous regulators. Also reviewed are various disorders, including cardiovascular, neurological, renal, and metabolic diseases, purported to involve dysfunction of Na,K-ATPase activity. The escalation in knowledge at the molecular level concerning sodium pump function foreshadows application of this knowledge in the clinical laboratory to identify individuals at risk for Na,K-ATPase-associated diseases.
Rose
A M
AM
Department of Pathology, University of Louisville School of Medicine, KY 40292.
Valdes
R
R
D002301:Cardiac Glycosides / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000378:metabolism; D004077:Digoxin / Q000633:toxicity; D005333:Fetus / Q000002:abnormalities; D006801:Humans; D008171:Lung Diseases / Q000378:metabolism; D008659:Metabolic Diseases / Q000378:metabolism; D009422:Nervous System Diseases / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology*; D013329:Structure-Activity Relationship
D002301:Cardiac Glycosides; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase